134 related articles for article (PubMed ID: 36153254)
1. Disruption of striatal dopaminergic pathway: A new plot twist in dystonia genetic story.
Wirth T
Rev Neurol (Paris); 2022 Oct; 178(8):751-753. PubMed ID: 36153254
[No Abstract] [Full Text] [Related]
2. Early-Onset Dystonia, Exacerbation With Fever, and Striatal Signal Changes: Emerging Phenotype of DYT-
Bhowmick SS; Raha S; Bohora A
Neurology; 2022 Aug; 99(5):206-207. PubMed ID: 35914940
[No Abstract] [Full Text] [Related]
3. Evidence for striatal dopaminergic overactivity in paroxysmal dystonia indicated by microinjections in a genetic rodent model.
Rehders JH; Löscher W; Richter A
Neuroscience; 2000; 97(2):267-77. PubMed ID: 10799758
[TBL] [Abstract][Full Text] [Related]
4. Dystonia and dopamine: From phenomenology to pathophysiology.
Ribot B; Aupy J; Vidailhet M; Mazère J; Pisani A; Bezard E; Guehl D; Burbaud P
Prog Neurobiol; 2019 Nov; 182():101678. PubMed ID: 31404592
[TBL] [Abstract][Full Text] [Related]
5. Variability of presynaptic nigrostriatal dopaminergic function and clinical heterogeneity in a dopa-responsive dystonia family with GCH-1 gene mutation.
Lin JJ; Lu CS; Tsai CH
J Neurol; 2018 Mar; 265(3):478-485. PubMed ID: 29290055
[TBL] [Abstract][Full Text] [Related]
6. Striatal dopaminergic dysfunction at rest and during task performance in writer's cramp.
Berman BD; Hallett M; Herscovitch P; Simonyan K
Brain; 2013 Dec; 136(Pt 12):3645-58. PubMed ID: 24148273
[TBL] [Abstract][Full Text] [Related]
7. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine.
Tabbal SD; Mink JW; Antenor JA; Carl JL; Moerlein SM; Perlmutter JS
Neuroscience; 2006 Sep; 141(3):1281-7. PubMed ID: 16766129
[TBL] [Abstract][Full Text] [Related]
8. Recessive NUP54 Variants Underlie Early-Onset Dystonia with Striatal Lesions.
Harrer P; Schalk A; Shimura M; Baer S; Calmels N; Spitz MA; Warde MA; Schaefer E; Kittke VMS; Dincer Y; Wagner M; Dzinovic I; Berutti R; Sato T; Shirakawa T; Okazaki Y; Murayama K; Oexle K; Prokisch H; Mall V; Melčák I; Winkelmann J; Zech M
Ann Neurol; 2023 Feb; 93(2):330-335. PubMed ID: 36333996
[TBL] [Abstract][Full Text] [Related]
9. PRKRA-Related Disorders: Bilateral Striatal Degeneration in Addition to DYT16 Spectrum.
Masnada S; Martinelli D; Correa-Vela M; Agolini E; Baide-Mairena H; Marcé-Grau A; Parazzini C; Veggiotti P; Perez-Duenas B; Tonduti D
Mov Disord; 2021 Apr; 36(4):1038-1040. PubMed ID: 33606314
[No Abstract] [Full Text] [Related]
10. Striatal dopaminergic dysregulation and dystonia-like movements induced by sensorimotor stress in a pharmacological mouse model of rapid-onset dystonia-parkinsonism.
Rauschenberger L; Knorr S; Al-Zuraiqi Y; Tovote P; Volkmann J; Ip CW
Exp Neurol; 2020 Jan; 323():113109. PubMed ID: 31712125
[TBL] [Abstract][Full Text] [Related]
11. Striatal dysfunction in X-linked dystonia-parkinsonism is associated with disease progression.
Brüggemann N; Rosales RL; Waugh JL; Blood AJ; Domingo A; Heldmann M; Jamora RD; Münchau A; Münte TF; Lee LV; Buchmann I; Klein C
Eur J Neurol; 2017 May; 24(5):680-686. PubMed ID: 28236370
[TBL] [Abstract][Full Text] [Related]
12. Are Dopa-responsive dystonia and Parkinson's disease related disorders? A case report.
Eggers C; Volk AE; Kahraman D; Fink GR; Leube B; Schmidt M; Timmermann L
Parkinsonism Relat Disord; 2012 Jun; 18(5):666-8. PubMed ID: 22030322
[TBL] [Abstract][Full Text] [Related]
13. Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia.
Eskow Jaunarajs KL; Bonsi P; Chesselet MF; Standaert DG; Pisani A
Prog Neurobiol; 2015 Apr; 127-128():91-107. PubMed ID: 25697043
[TBL] [Abstract][Full Text] [Related]
14. Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia.
Karimi M; Moerlein SM; Videen TO; Su Y; Flores HP; Perlmutter JS
Mov Disord; 2013 Dec; 28(14):2002-6. PubMed ID: 24151192
[TBL] [Abstract][Full Text] [Related]
15. Striatal increase of extracellular dopamine levels during dystonic episodes in a genetic model of paroxysmal dyskinesia.
Hamann M; Richter A
Neurobiol Dis; 2004 Jun; 16(1):78-84. PubMed ID: 15207264
[TBL] [Abstract][Full Text] [Related]
16. Models of dystonia: an update.
Imbriani P; Ponterio G; Tassone A; Sciamanna G; El Atiallah I; Bonsi P; Pisani A
J Neurosci Methods; 2020 Jun; 339():108728. PubMed ID: 32289333
[TBL] [Abstract][Full Text] [Related]
17. Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?
Karimi M; Moerlein SM; Videen TO; Luedtke RR; Taylor M; Mach RH; Perlmutter JS
Mov Disord; 2011 Jan; 26(1):100-6. PubMed ID: 20960437
[TBL] [Abstract][Full Text] [Related]
18. Alteration of striatal dopaminergic neurotransmission in a mouse model of DYT11 myoclonus-dystonia.
Zhang L; Yokoi F; Parsons DS; Standaert DG; Li Y
PLoS One; 2012; 7(3):e33669. PubMed ID: 22438980
[TBL] [Abstract][Full Text] [Related]
19. Plasticity, genetics and epigenetics in dystonia: An update.
Sciamanna G; El Atiallah I; Montanari M; Pisani A
Handb Clin Neurol; 2022; 184():199-206. PubMed ID: 35034734
[TBL] [Abstract][Full Text] [Related]
20. Cell-intrinsic effects of TorsinA(ΔE) disrupt dopamine release in a mouse model of TOR1A dystonia.
Downs AM; Fan X; Kadakia RF; Donsante Y; Jinnah HA; Hess EJ
Neurobiol Dis; 2021 Jul; 155():105369. PubMed ID: 33894367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
